Location History:
- Goteberg, SE (2005)
- Gothenburg, SE (2003 - 2023)
Company Filing History:
3 out of 15,471 
2 out of 2 
1 out of 1 Years Active: 2003-2023
Title: Jan Borén: Innovator in Fatty Liver Treatment
Introduction
Jan Borén is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of medical treatments, particularly focusing on fatty liver-related conditions. With a total of three patents to his name, Borén's work is paving the way for innovative solutions in healthcare.
Latest Patents
Borén's latest patents include a composition designed for the treatment of fatty liver-related conditions. This composition comprises several key ingredients, including serine, glycine, betaine, N-acetylglycine, and others. The formulation also includes N-acetyl cysteine and optional components like carnitine and nicotinamide riboside. The specific molar ratios of these components are carefully defined to ensure efficacy in treating conditions such as non-alcoholic fatty liver disease (NAFLD), alcoholic fatty liver disease (AFLD), type 2 diabetes, obesity, insulin resistance, and dyslipidemia.
Career Highlights
Throughout his career, Jan Borén has worked with various companies, including Scandibio Therapeutics AB and Scandiedge Therapeutics AB. His experience in these organizations has contributed to his expertise in developing innovative treatments for complex medical conditions.
Collaborations
Borén has collaborated with notable colleagues in his field, including Adil Mardinoglu and Mathias Uhlén. These partnerships have enhanced his research and development efforts, leading to advancements in medical treatments.
Conclusion
Jan Borén is a prominent inventor whose work in fatty liver treatment is making a significant impact in the medical field. His innovative compositions and collaborations are paving the way for better health outcomes for patients suffering from related conditions.